Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs864622007
rs864622007
AR
A 0.830 GeneticVariation CLINVAR

dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation UNIPROT

dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation BEFREE This mutant AR contains two mutations (L701H and T877A) and was previously reported as a high-affinity cortisol/cortisone responsive AR (AR(ccr)) isolated from the androgen-independent human prostate cancer cell lines MDA PCa 2a and 2b (Zhao et al.Nature Med.2000, 6, 703-6). 11906285

2002

dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation BEFREE Our results indicate that the specific amino acid residue at position 701, its interaction with the backbone of Ser(778), and the steroidal 17alpha-hydroxyl group of the ligand are all important for the distinct transcriptional responses to progesterone and cortisol of AR mutants, including the prostate cancer mutant L701H. 20007693

2010

dbSNP: rs864622007
rs864622007
AR
0.830 GeneticVariation BEFREE The cortisol/cortisone-responsive AR (AR(ccr)) has two mutations (L701H and T877A) that were found in the MDA PCa human prostate cancer cell lines established from a castrated patient whose metastatic tumor exhibited androgen-independent growth. 11956172

2002

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Regardless of race and ethnicity or rs10993994 genotype, men with low blood levels of MSP have increased risk of prostate cancer. 23213189

2013

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE In conclusion, loci associated with risk for prostate cancer, such as rs7920517 and rs10993994, might also be used to predict the recurrence of prostate-specific antigen in prostate cancer patients receiving radical prostatectomy. 19900942

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE PCa susceptibility was associated with TT genotype of SNP rs10993994 in this cohort of Scottish men and the increased risk of PCa was modified by serum enterolactone concentrations. 22733159

2012

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure. 23608167

2013

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Recent functional work has shown that different alleles of the significantly associated SNP in the promoter of MSMB found to be associated with prostate cancer risk, rs10993994, can influence its expression in tumors and in vitro studies. 19644707

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE For the two SNPs that had significant differences between more and less aggressive disease rs2735839 in KLK3 (P = 8.4 x 10(-7)) and rs10993994 in MSMB (P = 0.046), the alleles that are associated with increased risk for PCa were more frequent in patients with less aggressive disease. 19434657

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. 20967219

2010

dbSNP: rs10993994
rs10993994
T 0.800 GeneticVariation GWASDB Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544

2014

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Six markers associated with early-onset prostate cancer [rs2171492 (7q32), rs6983561 (8q24), rs10993994 (10q11), rs4430796 (17q12), rs1799950 (17q21), and rs266849 (19q13)] were genotyped. 22144497

2012

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation GWASDB Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population. 20676098

2010

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE SNP rs10993994 is 2 bp upstream of the transcription initiation site of MSMB and was identified as an associated PrCa risk variant. 19997100

2010

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Cells with prostate cancer risk alleles at rs10993994 seem to cope more efficiently with DNA double strand breaks (less MN) in a shorter time (decreased MD index). 22677538

2012

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Rs11672691 and rs10993994 were associated with both fatal and nonfatal PCa, while rs6465657, rs7127900, rs2735839, and rs13385191 were associated with nonfatal PCa only. 24411283

2014

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Our data indicated that MSMB gene rs10993994 polymorphism was associated with an increased risk of PC. 28212531

2017

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The observations that rs10993994 is the strongest associated variant in the region and its risk allele has a major effect on the transcriptional activity of MSMB, a gene with previously described prostate cancer suppressor function, together suggest the T allele of rs10993994 as a potential causal variant at 10q11 that confers increased risk of prostate cancer. 19153072

2009

dbSNP: rs10993994
rs10993994
T 0.800 GeneticVariation GWASDB Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The rs10993994 genotype in the MSMB gene modifies the association between number of sexual partners and PCa risk. 24037734

2013

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Genome-wide association studies (GWAS) have established a variant, rs10993994, on chromosome 10q11 as being associated with prostate cancer risk. 21085629

2010

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE These data indicate that the increase in PC risk associated with rs10993994:C>T is likely mediated by the variant's effect on PSP94 expression; however, this effect does not extend to NCOA4 in the data presented here. 22887727

2013

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Our results suggest a mechanism by which rs10993994 might predispose to prostate cancer and raise the possibility that genetic variation might need to be considered in interpreting the levels of these biomarkers. 20696662

2010